BDNF and peripheral nerve injury: Recent advances and pieces of evidence have made endogenous molecules like Brain-derived neurotrophic factor (BDNF) and pituitary adenylate cyclase-activating peptide (PACAP) the substance of choice for the therapeutic management of peripheral nerve injury (Pettersson et al. 2014).